Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75,401 | -$158,628 | -$160,868 | -$112,689 |
| Dep. & Amort. | $248 | $286 | $261 | $3,335 |
| Deferred Tax | $0 | $14,744 | $3,951 | -$1,674 |
| Stock-Based Comp. | $8,490 | $19,841 | $17,819 | $21,838 |
| Change in WC | -$35,224 | $2,647 | -$12,529 | -$21,893 |
| Other Non-Cash | $4,898 | $1,624 | $29,737 | -$23,548 |
| Operating Cash Flow | -$96,989 | -$119,486 | -$121,629 | -$134,631 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$273 | -$221 | -$5,535 | -$9,018 |
| Net Acquisitions | -$2,166 | $5,974 | -$3,954 | $158,571 |
| Inv. Purchases | -$34,578 | -$16,856 | -$89,382 | -$200,160 |
| Inv. Sales/Matur. | $8,133 | $125,788 | $112,989 | $82,549 |
| Other Inv. Act. | $2,166 | -$5,974 | $3,954 | $50 |
| Investing Cash Flow | -$26,718 | $108,711 | $18,072 | $31,992 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $46,561 | $52,621 | $84,567 | $1,817 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $75,591 | $53,310 | $85,230 | $9,627 |
| Financing Cash Flow | $75,591 | $53,310 | $85,230 | $9,627 |
| Forex Effect | -$55 | -$5 | -$82 | -$50 |
| Net Chg. in Cash | -$48,171 | $42,530 | -$18,409 | -$93,062 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,539 | $46,009 | $64,418 | $157,480 |
| End Cash | $40,368 | $88,539 | $46,009 | $64,418 |
| Free Cash Flow | -$97,262 | -$119,707 | -$127,164 | -$143,649 |